These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
432 related items for PubMed ID: 7604878
1. Mesangial cell-derived interleukin-10 modulates mesangial cell response to lipopolysaccharide. Fouqueray B, Boutard V, Philippe C, Kornreich A, Marchant A, Perez J, Goldman M, Baud L. Am J Pathol; 1995 Jul; 147(1):176-82. PubMed ID: 7604878 [Abstract] [Full Text] [Related]
2. Reprogramming of lipopolysaccharide-primed macrophages is controlled by a counterbalanced production of IL-10 and IL-12. Shnyra A, Brewington R, Alipio A, Amura C, Morrison DC. J Immunol; 1998 Apr 15; 160(8):3729-36. PubMed ID: 9558074 [Abstract] [Full Text] [Related]
3. Transforming growth factor-beta 1 is the predominant paracrine inhibitor of macrophage cytokine synthesis produced by glomerular mesangial cells . Kitamura M, Sütö T, Yokoo T, Shimizu F, Fine LG. J Immunol; 1996 Apr 15; 156(8):2964-71. PubMed ID: 8609417 [Abstract] [Full Text] [Related]
4. Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis. Wanidworanun C, Strober W. J Immunol; 1993 Dec 15; 151(12):6853-61. PubMed ID: 8258695 [Abstract] [Full Text] [Related]
6. Autocrine growth regulation of human glomerular mesangial cells is primarily mediated by basic fibroblast growth factor. Francki A, Uciechowski P, Floege J, von der Ohe J, Resch K, Radeke HH. Am J Pathol; 1995 Nov 15; 147(5):1372-82. PubMed ID: 7485400 [Abstract] [Full Text] [Related]
7. Altered nitric oxide production and exogenous nitric oxide do not affect the proliferation of rat mesangial cells. Mohaupt M, Schoecklmann HO, Schulze-Lohoff E, Sterzel RB. J Hypertens; 1994 Apr 15; 12(4):401-8. PubMed ID: 8064164 [Abstract] [Full Text] [Related]
8. Interleukin-10 is a mesangial cell growth factor in vitro and in vivo. Chadban SJ, Tesch GH, Foti R, Atkins RC, Nikolic-Paterson DJ. Lab Invest; 1997 May 15; 76(5):619-27. PubMed ID: 9166281 [Abstract] [Full Text] [Related]
9. Modulation by dantrolene of endotoxin-induced interleukin-10, tumour necrosis factor-alpha and nitric oxide production in vivo and in vitro. Haskó G, Szabó C, Németh ZH, Lendvai B, Vizi ES. Br J Pharmacol; 1998 Jul 15; 124(6):1099-106. PubMed ID: 9720779 [Abstract] [Full Text] [Related]
10. Lipopolysaccharide-induced interleukin-10 in mice: role of endogenous tumor necrosis factor-alpha. Barsig J, Küsters S, Vogt K, Volk HD, Tiegs G, Wendel A. Eur J Immunol; 1995 Oct 15; 25(10):2888-93. PubMed ID: 7589088 [Abstract] [Full Text] [Related]
11. Interleukin-1 beta and tumor necrosis factor-alpha induce gene expression and production of leukocyte chemotactic factors, colony-stimulating factors, and interleukin-6 in human mesangial cells. Zoja C, Wang JM, Bettoni S, Sironi M, Renzi D, Chiaffarino F, Abboud HE, Van Damme J, Mantovani A, Remuzzi G. Am J Pathol; 1991 Apr 15; 138(4):991-1003. PubMed ID: 2012180 [Abstract] [Full Text] [Related]
12. Selective inhibition of interleukin-1 beta gene expression in activated RAW 264.7 macrophages by interferon-gamma. Chujor CS, Klein L, Lam C. Eur J Immunol; 1996 Jun 15; 26(6):1253-9. PubMed ID: 8647201 [Abstract] [Full Text] [Related]
13. Interleukin 1 beta markedly stimulates nitric oxide formation in the absence of other cytokines or lipopolysaccharide in primary cultured rat hepatocytes but not in Kupffer cells. Kitade H, Sakitani K, Inoue K, Masu Y, Kawada N, Hiramatsu Y, Kamiyama Y, Okumura T, Ito S. Hepatology; 1996 Apr 15; 23(4):797-802. PubMed ID: 8666334 [Abstract] [Full Text] [Related]
14. Cytokine responses induced by Toxoplasma gondii in astrocytes and microglial cells. Fischer HG, Nitzgen B, Reichmann G, Hadding U. Eur J Immunol; 1997 Jun 15; 27(6):1539-48. PubMed ID: 9209508 [Abstract] [Full Text] [Related]
15. Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production. Trepicchio WL, Bozza M, Pedneault G, Dorner AJ. J Immunol; 1996 Oct 15; 157(8):3627-34. PubMed ID: 8871663 [Abstract] [Full Text] [Related]
16. Expression and release of tumor necrosis factor-alpha by explants of mouse cornea. Sekine-Okano M, Lucas R, Rungger D, De Kesel T, Grau GE, Leuenberger PM, Rungger-Brändle E. Invest Ophthalmol Vis Sci; 1996 Jun 15; 37(7):1302-10. PubMed ID: 8641833 [Abstract] [Full Text] [Related]
17. IL-10 inhibits cytokine production by activated macrophages. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. J Immunol; 1991 Dec 01; 147(11):3815-22. PubMed ID: 1940369 [Abstract] [Full Text] [Related]
18. Specific transcriptional inhibition of bone marrow-derived macrophage tumor necrosis factor-alpha gene expression and protein production using novel enantiomeric carbocyclic nucleoside analogues. Bradshaw M, Rutherford MS, Hoeper BJ, McWhinney CD, Borcherding DR, Schook LB, Edwards CK. J Pharmacol Exp Ther; 1995 Jun 01; 273(3):1506-18. PubMed ID: 7791126 [Abstract] [Full Text] [Related]
19. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes. Seldon PM, Barnes PJ, Giembycz MA. Cell Biochem Biophys; 1998 Jun 01; 29(1-2):179-201. PubMed ID: 9631245 [Abstract] [Full Text] [Related]
20. Neuroprotective effects of cyclooxygenase-2 inhibitor celecoxib against toxicity of LPS-stimulated macrophages toward motor neurons. Huang Y, Liu J, Wang LZ, Zhang WY, Zhu XZ. Acta Pharmacol Sin; 2005 Aug 01; 26(8):952-8. PubMed ID: 16038627 [Abstract] [Full Text] [Related] Page: [Next] [New Search]